INX-315 is an orally potent and selective CDK2 inhibitor that induces cell cycle arrest in G1 phase. INX-315 also induces CDK2 substrate phosphorylation and inhibits tumor growth in a dose-dependent manner in a xenograft mouse model.INX-315 can be used in cancer-related studies.
Molecular Weight:
427.48
Purity:
>99.0%
CAS Number:
[2745060-92-6]
Formula:
C19H21N7O3S
Target:
CDK
* VAT and and shipping costs not included. Errors and price changes excepted